QIAN-BO HAN

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Non-small cell lung cancer is a subtype of adenocarcinoma, which has previously shown positive responses to gefitinib. The aim of the current study was to determine a clinical profile of gefitinib-induced disease controls for patients with lung adenocarcinoma. Retrospective evaluation of the clinical characteristics of 52 lung adenocarcinoma patients,(More)
  • 1